Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

ATC code L

From Wikipedia, the free encyclopedia
Pharmaceutical drug classification
ATC code L: Antineoplastic and immunomodulating agents
Other ATC codes

ATC code LAntineoplastic and immunomodulating agents is a section of theAnatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by theWorld Health Organization (WHO) for the classification ofdrugs and other medical products.[1][2][3][4]

Codes forveterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example,QL.[5]
National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.

References

[edit]
  1. ^"ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis".National Institutes of Health. Retrieved1 February 2020.
  2. ^"Anatomical Therapeutic Chemical (ATC) Classification".World Health Organization. Retrieved3 January 2022.
  3. ^"Structure and principles".WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved3 January 2022.
  4. ^"ATC/DDD Index 2022: code L".WHO Collaborating Centre for Drug Statistics Methodology.
  5. ^"ATCvet Index 2022: code QL".WHO Collaborating Centre for Drug Statistics Methodology.
Major chemical drug groups – based upon theAnatomical Therapeutic Chemical Classification System
gastrointestinal tract
/metabolism (A)
blood and blood
forming organs (B)
cardiovascular
system
(C)
skin (D)
genitourinary
system
(G)
endocrine
system
(H)
infections and
infestations (J,P,QI)
malignant disease
(L01–L02)
immune disease
(L03–L04)
muscles,bones,
andjoints (M)
brain and
nervous system (N)
respiratory
system
(R)
sensory organs (S)
otherATC (V)
SPs/MIs
(M phase)
Blockmicrotubule assembly
Block microtubule disassembly
DNA replication
inhibitor
DNA precursors/
antimetabolites
(S phase)
Folic acid
Purine
Pyrimidine
Deoxyribonucleotide
Topoisomerase inhibitors
(S phase)
I
II
II+Intercalation
Crosslinking of DNA
(CCNS)
Alkylating
Platinum-based
Nonclassical
Intercalation
Photosensitizers/PDT
Other
Enzyme inhibitors
Receptor antagonists
Other/ungrouped
CImonoclonal antibodies ("-mab")
Receptor tyrosine kinase
Others for solid tumors
Leukemia/lymphoma
Other
Tyrosine kinase inhibitors ("-nib")
Receptor tyrosine kinase
Non-receptor
Other
Endogenous
Cytokines
Colony-stimulating factors
Interferons
Interleukins
Other protein / peptide
Other
Exogenous
Intracellular
(initiation)
Antimetabolites
Macrolides/
otherIL-2 inhibitors
IMiDs
JAK inhibitors
Intracellular
(reception)
IL-1 receptor antagonists
mTOR
Extracellular
Antibodies
Monoclonal
Serum target
(noncellular)
Cellular
target
Unsorted
Polyclonal
-cept (Fusion)
Unsorted
Stub icon

Thispharmacology-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=ATC_code_L&oldid=1250193286"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp